Volume 31, Issue 202 (11-2021)
J Mazandaran Univ Med Sci 2021, 31(202): 168-178 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Karimi Aliabadi P, Bahar A, Nabati M, Sohrab M. A Brief Overview of the Latest Treatment Guidelines for Lipid Disorders in Primary Prevention of Cardiovascular
Disease in Adults. J Mazandaran Univ Med Sci 2021; 31 (202) :168-178
URL: http://jmums.mazums.ac.ir/article-1-15532-en.html
URL: http://jmums.mazums.ac.ir/article-1-15532-en.html
Abstract: (1236 Views)
Background and purpose: Increased urbanization in developing countries has led to increase in non-communicable diseases such as cardiovascular disease. Primary prevention of atherosclerotic vascular disease could be achieved by promoting healthy lifestyle throughout life. Team care approach is an effective strategy to prevent cardiovascular disease. Physicians should consider social factors affecting health to make appropriate treatment decisions. The present study will provide a brief overview of the latest clinical guidelines for treatment of lipid disorders in primary prevention of cardiovascular disease in adults.
Materials and methods: In this narrative review, a comprehensive search of electronic databases (pubmed, scopus, google scholar, uptodate, and Embace) was done using the following keywords: primary prevention, cardiovascular disease, LDL cholesterol, and guideline. The goal of this study was to review the latest guidelines for lipid treatment in prevention of cardiovascular disease from 2015 onwards. Six articles were obtained in this field.
Results: To prevent cardiovascular disease in diabetic patients aged 40-75 years, a moderate dose of statin is recommended. In non-diabetic patients, high-dose statin should be given for LDL levels ≥ 190 mg/dL. Also, 10-year risk of atherosclerotic heart disease should be calculated in non-diabetic patients aged 40-75 years old with LDL levels of 70-190 mg/dL to make treatment decisions.
Conclusion: According to access to the latest clinical guidelines, depending on patient's condition and type of disorder, therapeutic interventions in lipid disorders are recommended for primary prevention of cardiovascular disease.
Materials and methods: In this narrative review, a comprehensive search of electronic databases (pubmed, scopus, google scholar, uptodate, and Embace) was done using the following keywords: primary prevention, cardiovascular disease, LDL cholesterol, and guideline. The goal of this study was to review the latest guidelines for lipid treatment in prevention of cardiovascular disease from 2015 onwards. Six articles were obtained in this field.
Results: To prevent cardiovascular disease in diabetic patients aged 40-75 years, a moderate dose of statin is recommended. In non-diabetic patients, high-dose statin should be given for LDL levels ≥ 190 mg/dL. Also, 10-year risk of atherosclerotic heart disease should be calculated in non-diabetic patients aged 40-75 years old with LDL levels of 70-190 mg/dL to make treatment decisions.
Conclusion: According to access to the latest clinical guidelines, depending on patient's condition and type of disorder, therapeutic interventions in lipid disorders are recommended for primary prevention of cardiovascular disease.
Keywords: dyslipidemia, LDL cholesterol, cardiovascular disease, primary prevention, clinical guideline
Type of Study: Review |
Subject:
Endocrine diseases
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Articles Copyright © The Author(s). Owned by Mazandaran University of Medical Sciences.
Contact Us
Address: Journal Office, Building No. 2, Mazandaran University of Medical Sciences, Moallem Square, Sari.Tel: +98 (011)34484874 Postal code: 48175-866 E-Mail: jmums@mazums.ac.ir Telefax: +98 (011)33262679
